Imaging Tumor Blood Vessels and Treatment Response in Mice
Author Information
Author(s): Ullrich Roland T., Jikeli Jan F., Diedenhofen Michael, Böhm-Sturm Philipp, Unruh Maike, Vollmar Stefan, Hoehn Mathias
Primary Institution: Max Planck Institute for Neurological Research, Cologne, Germany
Hypothesis
Can in vivo MRI effectively monitor tumor microvessel density and response to anti-angiogenic treatment in a mouse model?
Conclusion
The study presents a new MRI approach that can monitor tumor microvessel density and size, showing potential for assessing anti-angiogenic treatment effects.
Supporting Evidence
- The MRI approach allowed for simultaneous imaging of tumor microvessel density and size.
- Microvessel density increased within 8 days after tumor implantation.
- PTK787 treatment led to a significant decline in microvessel density after 6 days.
Takeaway
Researchers used special MRI techniques to see how blood vessels in tumors change when treated with a cancer drug in mice.
Methodology
The study used in vivo MRI to measure tumor microvessel density and size in a mouse model of non-small cell lung cancer.
Limitations
The study was conducted in a mouse model, which may not fully replicate human tumor behavior.
Participant Demographics
NSCLC xenograft model in nu/nu athymic male mice.
Statistical Information
P-Value
0.021
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website